Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Orally Administered BPM31510 on Mitochondrial Energetics in Older

NCT04999488 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.

NCT NCT04999488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04999488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Orally Administered BPM31510 on Mitochondrial Energetics in Older
Lead sponsor
AdventHealth Translational Research Institute
Phase
Phase 1
Overall status
Withdrawn
Start date
December 31, 2023
Completion date
December 31, 2024
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcopenia